FSD Pharma (HUGE) Competitors

FSD Pharma (NASDAQ:HUGE) and Pieris Pharmaceuticals (NASDAQ:PIRS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, community ranking, earnings, profitability, valuation, institutional ownership and risk.

Do analysts prefer HUGE or PIRS?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FSD Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Pieris Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has better earnings & valuation, HUGE or PIRS?

FSD Pharma has higher earnings, but lower revenue than Pieris Pharmaceuticals. FSD Pharma is trading at a lower price-to-earnings ratio than Pieris Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FSD Pharma	N/A	N/A	-$17.90M	-$0.26	-1.35
Pieris Pharmaceuticals	$42.81M	0.34	-$24.54M	-$11.95	-0.94

Does the media prefer HUGE or PIRS?

In the previous week, FSD Pharma and FSD Pharma both had 4 articles in the media. FSD Pharma's average media sentiment score of 0.50 beat Pieris Pharmaceuticals' score of -0.24 indicating that FSD Pharma is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FSD Pharma	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pieris Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is HUGE or PIRS more profitable?

FSD Pharma has a net margin of 0.00% compared to Pieris Pharmaceuticals' net margin of -39.71%. Pieris Pharmaceuticals' return on equity of -57.57% beat FSD Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FSD Pharma	N/A	-70.35%	-52.56%
Pieris Pharmaceuticals	-39.71%	-57.57%	-32.05%

Does the MarketBeat Community prefer HUGE or PIRS?

Pieris Pharmaceuticals received 278 more outperform votes than FSD Pharma when rated by MarketBeat users. Likewise, 61.50% of users gave Pieris Pharmaceuticals an outperform vote while only 0.00% of users gave FSD Pharma an outperform vote.

Company	Underperform	Outperform
FSD Pharma	Outperform Votes No Votes	Underperform Votes 1 100.00%
Pieris Pharmaceuticals	Outperform Votes 278 61.50%	Underperform Votes 174 38.50%

Which has more volatility & risk, HUGE or PIRS?

FSD Pharma has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Pieris Pharmaceuticals has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of HUGE or PIRS?

1.2% of FSD Pharma shares are held by institutional investors. Comparatively, 40.1% of Pieris Pharmaceuticals shares are held by institutional investors. 8.5% of FSD Pharma shares are held by insiders. Comparatively, 8.9% of Pieris Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Pieris Pharmaceuticals beats FSD Pharma on 8 of the 13 factors compared between the two stocks.